Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice

Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, Eva Kassi
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMC 2018-07-01
Serie:Cardiovascular Diabetology
Ämnen:
Canagliflozin
SGLT2i
Atherosclerosis
Inflammation
APOE knockout mice
Länkar:http://link.springer.com/article/10.1186/s12933-018-0749-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk